I have also been here since the Milby years. In fact, I saw him do a presentation in 2015 at the famous (now infamous?) Vegas Wynn shindig. I sold half my shares at a bit over $16 back in- what was in 2021?- in the run up to the first FDA approval date. Then came the first CRL. I have bought shares at intervals over the past few years on the way down. My ASP is $4.60. Like most people (I think), I was expecting a nice run up into last week's FDA approval date; not to the level we reached in 2021, but to around $10. So, yeah...I am surprised we are still sitting here under $4, especially after receiving approval. Anyway, I have a lot of patience and will just wait and see where it goes. I continue to appreciate the insights provided by some of the excellent posters here. Good luck to all of us.